TNF and psoriasis: Anti-TNF-α therapy in patients with severe psoriasis has been shown to improve subclinical cardiovascular disease (abnormalities in echocardiogram) [13], improve coronary microvascular function (determined by transthoracic Doppler echocardiography) [274], and attenuate the progression in coronary artery disease (assessed by coronary computed tomography) [275].